
Investing.com -- Shares in Uber Technologies Inc (NYSE:UBER) spiked in premarket U.S. trading on Tuesday after the ride-hailing company posted better-than-expected revenue in the first quarter.
The San Francisco-based group, whose business also includes services like food delivery and freight transport, reported a 29% increase in revenue compared to the same period last year, reflecting a surge in post-pandemic travel demand. The top-line figure was above Bloomberg consensus estimates of $8.72 billion.
Gross bookings gained nearly a fifth to $31.4B, while total trips taken over January to March grew by 24% to 2.1B - or about 24 million journeys a day on average.
Adjusted earnings before interest, tax, depreciation and amortization - one of the company's most closely watched measures of profitability - jumped by more than four-fold to $761M, also ahead of projections.
Uber now expects to report growth in gross bookings to between $33B and $34B in the second quarter, while adjusted core earnings are seen rising between $800M and $850M.
"Overall, this was a quarter Uber should frame in its [headquarters] as it speaks to a 'new and improved' Uber story going forward with adults in the room," analysts at Wedbush said in a note to clients.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.